Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Psychiatry/Psychology
Study Phase : Undisclosed
Sponsor : March Of Dimes
Deal Size : $1.1 million
Deal Type : Funding
Details : The current Innovative Challenge Grant allows Katana Pharmaceutical to develop a novel non-opioid treatment for neonatal abstinence syndrome (NAS).
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
April 06, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Sponsor : March Of Dimes
Deal Size : $1.1 million
Deal Type : Funding